Unmasking Adrenal Crisis: A Review of Pembrolizumab and its Immune-related Adverse Events

20250 citationsReviewgold Open Access

Authors

Shamsher Singh · Christus Health

Blake G. Fitch · Christus Health

Chinaza Nweke · Christus Health

Michael R. Price · Christus Health

Akeil Shams-ul-hooda · Philadelphia College of Osteopathic Medicine

Madhu Chiluveri · Christus Health

Larry E. Frase ·

Abstract

Introduction Pembrolizumab is a monoclonal antibody used to treat various cancers via monotherapy or in conjunction with other chemotherapeutic regimens. Randomized-control trials report adrenal insufficiency in approximately 0.7% of patients on pembr

Topics & Keywords

Cancer Immunotherapy and Biomarkers Adrenal Hormones and Disorders Colorectal Cancer Treatments and Studies

UN Sustainable Development Goals

Zero hunger

Publication Details

DOI: 10.22541/au.175248753.34158735/v1

Field-Weighted Citation Impact: 0.00

Command Palette